Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.730
+0.090 (2.47%)
At close: Sep 18, 2025, 4:00 PM EDT
3.730
0.00 (0.00%)
After-hours: Sep 18, 2025, 4:10 PM EDT
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
$192,594
Profits / Employee
-$38,534
Market Cap
1.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Dec 31, 2021 | 4,198 | 626 | 17.53% |
| Dec 31, 2020 | 3,572 | 542 | 17.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVO News
- 5 weeks ago - Evotec SE (EVO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution - Accesswire
- 6 weeks ago - Evotec SE to announce first half-year results 2025 on 13 August 2025 - Accesswire
- 7 weeks ago - Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site - Accesswire
- 7 weeks ago - Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site - Accesswire
- 2 months ago - Evotec: Recovery Seems To Be Beginning - Seeking Alpha
- 2 months ago - Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 2 months ago - Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix - Accesswire